{
    "eid": "2-s2.0-85008422679",
    "title": "Difference in the incidences of hypersensitivity reactions to original and generic taxanes",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Drug Discovery",
            "@code": "3002"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "Docetaxel",
        "Generic drugs",
        "Hypersensitivity reaction",
        "Paclitaxel"
    ],
    "authors": [
        "Tanchanok Ratanajarusiri"
    ],
    "citedby-count": 19,
    "ref-count": 21,
    "ref-list": [
        "Paclitaxel (Taxol)",
        "Coping with toxicities of docetaxel (Taxotere\u2122)",
        "Short-course intravenous prophylaxis for paclitaxel-telated hypersensitivity reactions",
        "European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion",
        "Single-dose dexamethasone paclitaxel premedication",
        "Taxol hypersensitivity: Rapid retreatment is safe and cost effective",
        "Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel [3]",
        "Paclitaxel hypersensitivity reactions: Assessment of the utility of a test-dose program",
        "Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions [2]",
        "Common Terminology Criteria for Adverse Events, v3.0",
        "A comparative analysis on the efficacy and safety of intaxelspi\u00ae and taxolspi\u00ae in advanced metastatic breast cancer",
        "Evaluation of safety in clinical use of generic paclitaxel [NK] for injection",
        "Comparison of Serious Adverse Events Between the Original and a Generic Docetaxel in Breast Cancer Patients",
        "New cutaneous toxicities with generic docetaxel: are the excipients guilty?",
        "Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro study",
        "Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, tween-80 and tween-20",
        "Immunoglobulin E-mediated severe anaphylaxis to paclitaxel",
        "Successful parenteral desensitization to paclitaxel",
        "Biologic-induced urticaria due to polysorbate 80: Usefulness of prick test",
        "An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity [1]",
        "Pharmaceutical quality of docetaxel generics versus originator drug product: A comparative analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadapisek Sompoch Endowment Fund",
        "Chulalongkorn University",
        "Chulalongkorn University"
    ]
}